Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 21 , ISSUE 1 ( 2017 ) > List of Articles

BRIEF COMMUNICATION

Zinc supplementation in adult mechanically ventilated trauma patients is associated with decreased occurrence of ventilator-associated pneumonia: A secondary analysis of a prospective, observational study

Farshad Kiabi, Abbas Alipour, Hadi Darvishi-Khezri, Aily Aliasgharian, Amir Zeydi

Keywords : Intensive Care Units, supplementation, ventilator-associated pneumonia, zinc sulfate

Citation Information : Kiabi F, Alipour A, Darvishi-Khezri H, Aliasgharian A, Zeydi A. Zinc supplementation in adult mechanically ventilated trauma patients is associated with decreased occurrence of ventilator-associated pneumonia: A secondary analysis of a prospective, observational study. Indian J Crit Care Med 2017; 21 (1):34-39.

DOI: 10.4103/0972-5229.198324

License: CC BY-ND 3.0

Published Online: 00-01-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Ventilator-associated pneumonia (VAP) is a type of lung infection that typically affects critically ill patients undergoing mechanical ventilation (MV) in the Intensive Care Unit (ICU). The aim of this analysis is to determine potential association between zinc supplementation with the occurrence of VAP in adult mechanically ventilated trauma patients. Subjects and Methods: This secondary analysis of a prospective observational study was carried out over a period of 1 year in ICUs of one teaching hospital in Iran. A total of 186 adults mechanically ventilated trauma patients, who required at least 48 h of MV and received zinc sulfate supplement (n = 82) or not (n = 104) during their ICU stay, were monitored for the occurrence of VAP until their discharge from the ICU or death. Results: Forty-one of 186 patients developed VAP, 29.09 days after admission (95% confidence interval [CI]: 26.27-31.9). The overall incidence of VAP was 18.82 cases per 1000 days of intubation (95% CI: 13.86-25.57). Patients who received zinc sulfate supplement have smaller hazard of progression to VAP than others (hazard ratio: 0.318 [95% CI: 0.138-0.732]; P < 0.0001). Conclusion: The findings show that zinc supplementation may be associated with a significant reduction in the occurrence of VAP in adult mechanically ventilated trauma patients. Further well-designed randomized clinical trials to confirm the efficacy of this potential preventive modality are warranted.


PDF Share
  1. Darvishi Khezri H, Emami Zeydi A, Gholipour Baradari A, Mahmoodi GH, Hasanzadeh Kiabi F, Moghaddasifar I. The importance of oral hygiene in prevention of Ventilator-associated pneumonia (VAP): A literature review. Int J Caring Sci 2014;7:12-23.
  2. Shah GS, Dutta AK, Shah D, Mishra OP. Role of zinc in severe pneumonia: A randomized double bind placebo controlled study. Ital J Pediatr 2012;38:36.
  3. Carcillo J, Holubkov R, Dean JM, Berger J, Meert KL, Anand KJ, et al. Rationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. JPEN J Parenter Enteral Nutr 2009;33:368-74.
  4. Gholipour Baradari A, Hoseini SH, Zamani Kiasari A, Ala S, Emami Zeydi A, Mahdavi A, et al. Effect of Zinc Supplement on Job Stress of ICU Nurses. J Babol Univ Med Sci(JBUMS) 2013;15:38-45.
  5. Valavi E, Hakimzadeh M, Shamsizadeh A, Aminzadeh M, Alghasi A. The efficacy of zinc supplementation on outcome of children with severe pneumonia. A randomized double-blind placebo-controlled clinical trial. Indian J Pediatr 2011;78:1079-84.
  6. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, et al. Zinc supplementation decreases incidence of infections in the elderly: Effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007;85:837-44.
  7. Brooks WA, Yunus M, Santosham M, Wahed MA, Nahar K, Yeasmin S, et al. Zinc for severe pneumonia in very young children: Double-blind placebo-controlled trial. Lancet 2004;363:1683-8.
  8. Cander B, Dundar ZD, Gul M, Girisgin S. Prognostic value of serum zinc levels in critically ill patients. Crit Care 2010;14:42-6.
  9. Keyt H, Faverio P, Restrepo MI. Prevention of ventilator-associated pneumonia in the Intensive Care Unit: A review of the clinically relevant recent advancements. Indian J Med Res 2014;139:814-21.
  10. Pugin J. Clinical signs and scores for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol 2002;68:261-5.
  11. Chastre J, Fagon JY. Diagnosis of ventilator-associated pneumonia. N Engl J Med 2007;356:1469.
  12. Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP. Ventilator-associated pneumonia in a tertiary care intensive care unit: Analysis of incidence, risk factors and mortality. Indian J Crit Care Med 2014;18:200-4.
  13. Khalifehzadeh A, Parizade A, Hosseini A, Yousefi H. The effects of an oral care practice on incidence of pneumonia among ventilator patients in ICUs of selected hospitals in Isfahan, 2010. Iran J Nurs Midwifery Res 2012;17:216-9.
  14. Fahimi F, Ghafari S, Jamaati H, Baniasadi S, Tabarsi P, Najafi A, et al. Continuous versus intermittent administration of piperacillin-tazobactam in Intensive Care Unit patients with ventilator-associated pneumonia. Indian J Crit Care Med 2012;16:141-7.
  15. Wilkinson TS, Morris AC, Kefala K, O′Kane CM, Moore NR, Booth NA, et al. Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lung. Chest 2012;142:1425-32.
  16. Chiang TY, Tsao SM, Yeh CB, Yang SF. Matrix metalloproteinases in pneumonia. Clin Chim Acta 2014;433:272-7.
  17. Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007;82:1375-81.
  18. Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, et al. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr 2007;86:1167-73.
  19. Barnett JB, Hamer DH, Meydani SN. Low zinc status: A new risk factor for pneumonia in the elderly? Nutr Rev 2010;68:30-7.
  20. Srinivasan MG, Ndeezi G, Mboijana CK, Kiguli S, Bimenya GS, Nankabirwa V, et al. Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: A randomized double blind placebo-controlled trial. BMC Med 2012;10:14.
  21. Lassi ZS, Haider BA, Bhutta ZA. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2010;12:CD005978.
  22. Mocchegiani E, Giacconi R, Muzzioli M, Cipriano C. Zinc, infections and immunosenescence. Mech Ageing Dev 2000;121:21-35.
  23. Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112-24.
  24. Prasad AS. Zinc: Role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009;12:646-52.
  25. Thurnham DI. An overview of interactions between micronutrients and of micronutrients with drugs, genes and immune mechanisms. Nutr Res Rev 2004;17:211-40.
  26. Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000;130 5S Suppl:1399S-406S.
  27. Namas RA, Vodovotz Y, Almahmoud K, Abdul-Malak O, Zaaqoq A, Namas R, et al. Temporal patterns of circulating inflammation biomarker networks differentiate susceptibility to nosocomial infection following blunt trauma in humans. Ann Surg 2016;263:191-8.
  28. Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today 1997;18:519-21.
  29. Mocchegiani E, Romeo J, Malavolta M, Costarelli L, Giacconi R, Diaz LE, et al. Zinc: Dietary intake and impact of supplementation on immune function in elderly. Age (Dordr) 2013;35:839-60.
  30. Bermejo-Martin JF, Martín-Loeches I, Bosinger S. Inflammation and infection in critical care medicine. Mediators Inflamm 2014;2014:456256.
  31. Ong CL, Gillen CM, Barnett TC, Walker MJ, McEwan AG. An antimicrobial role for zinc in innate immune defense against group A streptococcus. J Infect Dis 2014;209:1500-8.
  32. Besecker BY, Exline MC, Hollyfield J, Phillips G, Disilvestro RA, Wewers MD, et al. A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after Intensive Care Unit admission. Am J Clin Nutr 2011;93:1356-64.
  33. Wang G, Feng X, Yu X, Xu X, Wang D, Yang H, et al. Prognostic value of blood zinc, iron, and copper levels in critically ill children with pediatric risk of mortality score III. Biol Trace Elem Res 2013;152:300-4.
  34. Li X, Wang L, Yang Z, Tang X, Yuan Q, Deng L, et al. Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. Cochrane Database Syst Rev 2012;7:CD009946.
  35. Park SA, Cho SS, Kwak GJ. Factors influencing ventilator-associated pneumonia in cancer patients. Asian Pac J Cancer Prev 2014;15:5787-91.
  36. Anzueto A, Frutos-Vivar F, Esteban A, Bensalami N, Marks D, Raymondos K, et al. Influence of body mass index on outcome of the mechanically ventilated patients. Thorax 2011;66:66-73.
  37. Tsakiridou E, Makris D, Chatzipantazi V, Vlachos O, Xidopoulos G, Charalampidou O, et al. Diabetes and hemoglobin a1c as risk factors for nosocomial infections in critically ill patients. Crit Care Res Pract 2013;2013:279479.
  38. Michalia M, Kompoti M, Koutsikou A, Paridou A, Giannopoulou P, Trikka-Graphakos E, et al. Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med 2009;35:448-54.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.